Skip to main content
. 2013 Aug 7;305(7):F1006–F1013. doi: 10.1152/ajprenal.00407.2013

Fig. 4.

Fig. 4.

Cytosine methylation inhibits Sp1 binding to the αENaC promoter. mIMCD3 cells were treated in the presence of vehicle (v..) or the DNA methylation inhibitor 5-Aza-CdR (5..) as described in Fig. 3. Chromatin immunoprecipitation (ChIP)/qPCR analysis of the R3 subregion of the αENaC gene using anti-Sp1 antibodies (or nonimmune IgG as a negative control) was performed (n = 3). Error bars indicate ±SEs. *P < 0.05 vs. vehicle.